The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis
Background: This meta-analysis aims to evaluate the long-term efficacy of medication treatment vs. surgery treatment in patients with prolactinomas.Methods: An electronic literature search was performed using MEDLINE, EMBASE and Web of Science databases for studies dated before July in 2018. Patient...
Main Authors: | Qianquan Ma, Jun Su, Ying Li, Jiaxing Wang, Wenyong Long, Mei Luo, Qing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00636/full |
Similar Items
-
Treatment of hyperprolactinemia: a systematic review and meta-analysis
by: Wang Amy T, et al.
Published: (2012-07-01) -
Multiple vertebral fractures in an elderly male with macroprolactinoma
by: Saša Magaš, et al.
Published: (2016-09-01) -
Efficacy and safety of rapid escalation of cabergoline in comparison to conventional regimen for macroprolactinoma: A prospective, randomized trial
by: Ashu Rastogi, et al.
Published: (2012-01-01) -
Prolactin response to an acute bromocriptine suppression test (ABST) following surgical debulking of macroprolactinomas
by: Lora Stanka Kirigin, et al.
Published: (2016-06-01) -
Growth hormone deficiency, secondary hypothyroidism, and empty sella following treatment of childhood macroprolactinoma
by: Chitra Selvan, et al.
Published: (2013-01-01)